No Detail Found!

Development of a new rapid, economical and eco-friendly HPLC method for in vitro and in vivo determination of zolmitriptan

Author(s)
Kiramat Ali Shah College of Pharmaceutical Sciences, Soochow University,Suzhou,China
Binbin Gao Royal College of Surgeons in Ireland (RCSI),Dublin,Ireland
Qiu Ning Zhu College of Pharmaceutical Sciences, Soochow University,Suzhou,China
Robia Kamal College of Pharmaceutical Sciences, Soochow University,Suzhou,China
Anam Razzaq College of Pharmaceutical Sciences, Soochow University,Suzhou,China
Song Lina College of Pharmaceutical Sciences, Soochow University,Suzhou,China
Linyu Huang College of Pharmaceutical Sciences, Soochow University,Suzhou,China
Haroon Iqbal The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Caner Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences,Hangzhou, Zhejiang,China
Naveed Ullah Khan The University of Chenab,Gujrat, Punjab,Pakistan
Jing-Hao Cui College of Pharmaceutical Sciences, Soochow University,Suzhou,China
Abstract
Multiple high-performance liquid chromatographic (HPLC) approaches have been briefly defined for the assessment of zolmitriptan (ZMT). These methods are either cumbersome or require a plentiful volume of organic solvents, thus offering extortionate procedures. The objective of this study was to establish and validate a new rapid, ecofriendly and cost-effective HPLC method for the analysis of ZMT. The calibration curve for ZMT was established using simulated salivary fluid (SSF) and rat plasma for in-vitro and in-vivo analysis, respectively. Chromatogram separation was performed using a CST column (250mm × 4.6mm, 5µm) as a stationary phase and maintained at a temperature of 40°C. The methods were authenticated for linearity, system suitability, accuracy, precision, reproducibility, limit of detection (LOD) and limit of quantification (LOQ). The results of the validation variables and stability studies indicated that the methods were established in accordance with the guidelines of ICH and the USFDA. The established technique was time-saving, precise, eco- friendly and economical compared with the reported technique. In addition, the developed method was sufficiently repeatable for in vitro and in vivo analysis of ZMT.
Publication Details
Page(s) 1637-1646
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 6, Year: 2022

Request the full text from PASTIC

Keywords
RP-HPLC, method development and validation, ICH and USFDA guidelines, zolmitriptan, rizatriptan
0

Citations

0

Downloads

92

Views